Uipath Inc Financials
This page shows Uipath Inc (PATH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
UiPath’s economics now resemble a high-margin software model where cash generation arrived before reported profitability.
The real inflection was cash conversion, not headline earnings: free cash flow turned to$291.7M in FY2024 and stayed above$300M even while GAAP net income was still negative. That makes FY2026’s$282.3M profit look less dramatic than it seems, because a$181.7M tax benefit did part of the work that operations had only just begun to do.
Operating leverage came mainly from expense discipline below gross profit, not from cutting innovation; R&D spending still reached
Liquidity is still healthy, but the company is no longer preserving cash at all costs: cash declined to
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Uipath Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Uipath Inc has an operating margin of 3.5%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from -11.4% the prior year.
Uipath Inc's revenue grew 12.7% year-over-year to $1.6B, a solid pace of expansion. This earns a growth score of 67/100.
Uipath Inc has a moderate D/E ratio of 0.53. This balance of debt and equity financing earns a leverage score of 59/100.
With a current ratio of 2.31, Uipath Inc holds $2.31 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.
Uipath Inc converts 21.9% of revenue into free cash flow ($352.2M). This strong cash generation earns a score of 89/100.
Uipath Inc's ROE of 14.8% shows moderate profitability relative to equity, earning a score of 32/100. This is up from -4.3% the prior year.
Uipath Inc scores 3.42, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.3B) relative to total liabilities ($1.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Uipath Inc passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Uipath Inc generates $1.31 in operating cash flow ($371.2M OCF vs $282.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Uipath Inc generated $1.6B in revenue in fiscal year 2026. This represents an increase of 12.7% from the prior year.
Uipath Inc's EBITDA was $73.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 150.7% from the prior year.
Uipath Inc reported $282.3M in net income in fiscal year 2026. This represents an increase of 483.1% from the prior year.
Uipath Inc earned $0.52 per diluted share (EPS) in fiscal year 2026. This represents an increase of 500.0% from the prior year.
Cash & Balance Sheet
Uipath Inc generated $352.2M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 15.2% from the prior year.
Uipath Inc held $632.2M in cash against $0 in long-term debt as of fiscal year 2026.
Margins & Returns
Uipath Inc's gross margin was 83.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the prior year.
Uipath Inc's operating margin was 3.5% in fiscal year 2026, reflecting core business profitability. This is up 14.9 percentage points from the prior year.
Uipath Inc's net profit margin was 17.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 22.7 percentage points from the prior year.
Uipath Inc's ROE was 14.8% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 19.2 percentage points from the prior year.
Capital Allocation
Uipath Inc invested $385.2M in research and development in fiscal year 2026. This represents an increase of 1.2% from the prior year.
Uipath Inc spent $329.1M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 15.8% from the prior year.
Uipath Inc invested $19.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 27.6% from the prior year.
PATH Income Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $418.4M-13.0% | $481.1M+17.0% | $411.1M+13.7% | $361.7M+1.4% | $356.6M-15.8% | $423.6M+19.5% | $354.7M+12.1% | $316.3M |
| Cost of Revenue | $76.9M+4.0% | $73.9M+7.4% | $68.8M+6.9% | $64.4M+0.8% | $63.9M-1.0% | $64.5M+1.2% | $63.8M+0.7% | $63.3M |
| Gross Profit | $341.5M-16.1% | $407.2M+19.0% | $342.3M+15.1% | $297.3M+1.6% | $292.8M-18.5% | $359.1M+23.5% | $290.9M+15.0% | $252.9M |
| R&D Expenses | $92.9M-2.4% | $95.2M-1.8% | $96.9M-1.5% | $98.3M+3.7% | $94.8M-4.8% | $99.7M+2.8% | $97.0M-1.5% | $98.4M |
| SG&A Expenses | $52.7M-1.6% | $53.5M+0.7% | $53.2M+0.5% | $52.9M-3.3% | $54.7M+11.6% | $49.0M-2.2% | $50.1M-21.1% | $63.5M |
| Operating Income | $28.0M-65.1% | $80.3M+514.2% | $13.1M+164.8% | -$20.2M-23.0% | -$16.4M-148.8% | $33.6M+177.5% | -$43.4M+58.0% | -$103.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $18.4M+253.4% | -$12.0M+93.1% | -$174.2M-10097.0% | $1.7M-38.3% | $2.8M-0.1% | $2.8M+119.1% | -$14.8M-487.8% | $3.8M |
| Net Income | $22.5M-78.4% | $104.5M-47.5% | $198.8M+12453.0% | $1.6M+107.0% | -$22.6M-143.5% | $51.8M+586.1% | -$10.7M+87.6% | -$86.1M |
| EPS (Diluted) | $0.04 | N/A | $0.37 | $0.00+100.0% | $-0.04 | N/A | $-0.02+86.7% | $-0.15 |
PATH Balance Sheet
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B-8.6% | $3.2B+9.8% | $2.9B+11.7% | $2.6B-2.0% | $2.6B-7.7% | $2.9B+7.6% | $2.7B-1.4% | $2.7B |
| Current Assets | $1.9B-14.5% | $2.2B+7.2% | $2.1B+3.1% | $2.0B-3.7% | $2.1B-9.8% | $2.3B+7.4% | $2.2B-4.3% | $2.3B |
| Cash & Equivalents | $632.2M-27.4% | $871.2M+17.1% | $743.7M+18.3% | $628.6M-10.3% | $700.6M-20.3% | $879.2M+13.6% | $773.6M-17.6% | $939.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $300.0M-38.6% | $488.3M+33.1% | $366.8M+35.9% | $269.8M+1.2% | $266.6M-40.9% | $451.1M+34.2% | $336.1M+25.6% | $267.7M |
| Goodwill | $185.7M+48.2% | $125.3M+3.9% | $120.6M-0.1% | $120.8M-0.5% | $121.4M+39.0% | $87.3M-2.8% | $89.9M+0.4% | $89.5M |
| Total Liabilities | $1.0B-8.7% | $1.1B+12.9% | $971.4M+4.8% | $926.6M-2.0% | $946.0M-7.2% | $1.0B+9.5% | $931.4M+7.3% | $867.8M |
| Current Liabilities | $831.7M-8.1% | $905.4M+14.8% | $788.7M+6.8% | $738.4M+3.2% | $715.9M-10.4% | $798.9M+14.9% | $695.5M+10.0% | $632.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.9B-8.6% | $2.1B+8.2% | $1.9B+15.5% | $1.7B-1.9% | $1.7B-8.0% | $1.8B+6.6% | $1.7B-5.5% | $1.8B |
| Retained Earnings | -$1.7B+1.3% | -$1.7B+5.8% | -$1.8B+9.9% | -$2.0B+0.1% | -$2.0B-1.1% | -$2.0B+2.5% | -$2.0B-0.5% | -$2.0B |
PATH Cash Flow Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $131.9M-27.7% | $182.3M+545.0% | $28.3M-32.0% | $41.6M-65.1% | $119.0M-18.5% | $146.1M+420.4% | $28.1M-39.5% | $46.4M |
| Capital Expenditures | $2.7M-12.1% | $3.1M-3.5% | $3.2M | $0-100.0% | $12.8M+73.6% | $7.4M+51.6% | $4.9M+243.8% | $1.4M |
| Free Cash Flow | $129.2M-27.9% | $179.3M+614.1% | $25.1M-39.6% | $41.6M-60.8% | $106.2M-23.4% | $138.7M+497.9% | $23.2M-48.4% | $45.0M |
| Investing Cash Flow | -$112.8M-164.6% | -$42.7M-142.3% | $100.8M+15483.8% | -$655K+99.2% | -$79.9M-378.7% | -$16.7M+27.1% | -$22.9M+45.0% | -$41.7M |
| Financing Cash Flow | -$252.2M-1651.1% | -$14.4M-29.0% | -$11.2M+90.0% | -$111.6M+52.6% | -$235.2M-1284.8% | -$17.0M+90.2% | -$172.6M+19.8% | -$215.2M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $243.8M | $0 | $0-100.0% | $101.6M-55.4% | $227.5M+2333.9% | $9.3M-94.3% | $162.7M-17.3% | $196.7M |
PATH Financial Ratios
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 81.6%-3.0pp | 84.6%+1.4pp | 83.3%+1.1pp | 82.2%+0.1pp | 82.1%-2.7pp | 84.8%+2.7pp | 82.0%+2.0pp | 80.0% |
| Operating Margin | 6.7%-10.0pp | 16.7%+13.5pp | 3.2%+8.8pp | -5.6%-1.0pp | -4.6%-12.5pp | 7.9%+20.2pp | -12.2%+20.4pp | -32.7% |
| Net Margin | 5.4%-16.3pp | 21.7%-26.7pp | 48.4%+47.9pp | 0.4%+6.8pp | -6.3%-18.6pp | 12.2%+15.2pp | -3.0%+24.2pp | -27.2% |
| Return on Equity | 1.2%-3.8pp | 5.0%-5.3pp | 10.3%+10.2pp | 0.1%+1.4pp | -1.3%-4.1pp | 2.8%+3.4pp | -0.6%+4.1pp | -4.7% |
| Return on Assets | 0.8%-2.5pp | 3.3%-3.6pp | 6.9%+6.8pp | 0.1%+0.9pp | -0.9%-2.7pp | 1.8%+2.2pp | -0.4%+2.8pp | -3.2% |
| Current Ratio | 2.31-0.2 | 2.48-0.2 | 2.65-0.1 | 2.75-0.2 | 2.95+0.0 | 2.93-0.2 | 3.13-0.5 | 3.60 |
| Debt-to-Equity | 0.530.0 | 0.53+0.0 | 0.50-0.1 | 0.560.0 | 0.560.0 | 0.55+0.0 | 0.54+0.1 | 0.47 |
| FCF Margin | 30.9%-6.4pp | 37.3%+31.2pp | 6.1%-5.4pp | 11.5%-18.3pp | 29.8%-3.0pp | 32.7%+26.2pp | 6.5%-7.7pp | 14.2% |
Similar Companies
Frequently Asked Questions
What is Uipath Inc's annual revenue?
Uipath Inc (PATH) reported $1.6B in total revenue for fiscal year 2026. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Uipath Inc's revenue growing?
Uipath Inc (PATH) revenue grew by 12.7% year-over-year, from $1.4B to $1.6B in fiscal year 2026.
Is Uipath Inc profitable?
Yes, Uipath Inc (PATH) reported a net income of $282.3M in fiscal year 2026, with a net profit margin of 17.5%.
What is Uipath Inc's EBITDA?
Uipath Inc (PATH) had EBITDA of $73.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Uipath Inc's gross margin?
Uipath Inc (PATH) had a gross margin of 83.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Uipath Inc's operating margin?
Uipath Inc (PATH) had an operating margin of 3.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Uipath Inc's net profit margin?
Uipath Inc (PATH) had a net profit margin of 17.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Uipath Inc's return on equity (ROE)?
Uipath Inc (PATH) has a return on equity of 14.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Uipath Inc's free cash flow?
Uipath Inc (PATH) generated $352.2M in free cash flow during fiscal year 2026. This represents a 15.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Uipath Inc's operating cash flow?
Uipath Inc (PATH) generated $371.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Uipath Inc's total assets?
Uipath Inc (PATH) had $2.9B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Uipath Inc's capital expenditures?
Uipath Inc (PATH) invested $19.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Uipath Inc spend on research and development?
Uipath Inc (PATH) invested $385.2M in research and development during fiscal year 2026.
What is Uipath Inc's current ratio?
Uipath Inc (PATH) had a current ratio of 2.31 as of fiscal year 2026, which is generally considered healthy.
What is Uipath Inc's debt-to-equity ratio?
Uipath Inc (PATH) had a debt-to-equity ratio of 0.53 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Uipath Inc's return on assets (ROA)?
Uipath Inc (PATH) had a return on assets of 9.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Uipath Inc's Altman Z-Score?
Uipath Inc (PATH) has an Altman Z-Score of 3.42, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Uipath Inc's Piotroski F-Score?
Uipath Inc (PATH) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Uipath Inc's earnings high quality?
Uipath Inc (PATH) has an earnings quality ratio of 1.31x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Uipath Inc?
Uipath Inc (PATH) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.